CSK9 is a predictive biomarker of major adverse events after acute myocardial infarction. Hayek A, Leboube S, Brun C, Moulin F, et al. Int J Cardiol 2026 Jan 12:134176. doi: 10.1016/j.ijcard.2026.134176.

Read + Share

Amedeo Smart

Independent Medical Education

Hayek A, Leboube S, Brun C, Moulin F, et al. CSK9 is a predictive biomarker of major adverse events after acute myocardial infarction. Int J Cardiol 2026 Jan 12:134176. doi: 10.1016/j.ijcard.2026.134176.
PMID: 41534794